Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies

Autor: SN Rabinowe, RJ Soiffer, NJ Tarbell, D Neuberg, AS Freedman, J Seifter, KW Blake, JG Gribben, KC Anderson, T Takvorian

Publikováno v: Blood. 77(8)

One hundred and sixty eight adult patients with B-cell non-Hodgkin's lymphoma (NHL) and other hematologic malignancies who underwent autologous or allogeneic bone marrow transplantation (BMT) were investigated for the subsequent development of hemoly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5440c0230ae5429a0eddba54d9564bb2
https://pubmed.ncbi.nlm.nih.gov/2015407

Intravascular hemolysis and renal insufficiency after bone marrow transplantation

Autor: EC Guinan, NJ Tarbell, CM Niemeyer, SE Sallan, HJ Weinstein

Publikováno v: Blood. 72(2)

Renal disease has not been considered a major late complication of bone marrow transplantation. Of 31 evaluable pediatric patients undergoing allogeneic or autologous bone marrow transplantation for neuroblastoma or acute lymphoblastic leukemia, 14 d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a45d79c6cb9739d9a82687152404d643
https://pubmed.ncbi.nlm.nih.gov/3042040

Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy.

Autor: Liu KX; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Indelicato DJ; Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida., Paulino AC; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas., Looi WS; Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida., Catalano PJ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chintagumpala MM; Department of Pediatrics, Division of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Gallotto SL; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Marcus KJ; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Haas-Kogan DA; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Tarbell NJ; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Inspire Exercise Medicine, Naples, Florida., MacDonald SM; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Mahajan A; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Yock TI; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: tyock@mgh.harvard.edu.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Dec 01; Vol. 117 (5), pp. 1174-1180. Date of Electronic Publication: 2023 Jul 10.

Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing.

Autor: Baliga S; Department of Radiation Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Adams JA; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Bajaj BVM; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Van Benthuysen L; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Daartz J; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Gallotto SL; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Lewy JR; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., DeNunzio N; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Weyman EA; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Lawell MP; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Palmer JD; Department of Radiation Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Yeap BY; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Ebb DH; Department of Pediatric Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Huang MS; Department of Pediatric Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Perry AF; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., MacDonald SM; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Jones RM; Department of Pediatric Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA., Tarbell NJ; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA., Yock TI; Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Cancer [Cancer] 2023 Mar 01; Vol. 129 (5), pp. 764-770. Date of Electronic Publication: 2022 Dec 11.

Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience.

Autor: Saraf A; Harvard Radiation Oncology Program, Boston, Massachusetts, USA.; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Yock TI; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Niemierko A; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Oh KS; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Curry WT; Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA., Butler WE; Department of Pediatric Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA., Forst DA; Department of Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Arrillaga-Romany I; Department of Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Ebb DH; Department of Pediatric Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Tarbell NJ; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., MacDonald S; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Loeffler JS; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Inspire Oncology, Naples, Florida, USA., Shih HA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2022 Dec 01; Vol. 24 (12), pp. 2180-2189.